Aurinia Pharmaceuticals Inc (AUP.TO)
AUP.TO on Toronto Stock Exchange
8.47CAD
9:00pm BST
8.47CAD
9:00pm BST
Change (% chg)
$0.22 (+2.67%)
$0.22 (+2.67%)
Prev Close
$8.25
$8.25
Open
$8.28
$8.28
Day's High
$8.56
$8.56
Day's Low
$8.28
$8.28
Volume
45,682
45,682
Avg. Vol
56,606
56,606
52-wk High
$10.47
$10.47
52-wk Low
$6.61
$6.61
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Mar '19 | 0.03 | -0.138 |
| FY 2018 | Dec '18 | 0.03 | -0.171 |
| Sep '18 | 0.38 | -0.215 | |
| Jun '18 | 0.03 | -0.186 | |
| Mar '18 | 0.03 | -0.184 | |
| FY 2017 | Dec '17 | 0.03 | -0.040 |
| Sep '17 | 0.03 | -0.157 | |
| Jun '17 | 0.33 | -0.029 | |
| Mar '17 | 0.03 | -0.916 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-19 | 2 | 0.07 | 0.10 | 0.03 | -- |
| Quarter Ending Sep-19 | 2 | 0.07 | 0.10 | 0.03 | -- |
| Year Ending Dec-19 | 2 | 0.21 | 0.30 | 0.12 | 0.15 |
| Year Ending Dec-20 | 2 | 19.66 | 39.12 | 0.20 | 39.06 |
| Earnings (per share) | |||||
| Quarter Ending Jun-19 | 2 | -0.14 | -0.11 | -0.18 | -- |
| Quarter Ending Sep-19 | 2 | -0.15 | -0.10 | -0.20 | -- |
| Year Ending Dec-19 | 3 | -0.64 | -0.45 | -0.75 | -0.63 |
| Year Ending Dec-20 | 3 | -0.26 | 0.06 | -0.53 | -0.12 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 103.12 | 37.45 | |
| P/E High - Last 5 Yrs. | -- | 165.13 | 57.55 | |
| P/E Low - Last 5 Yrs. | -- | 52.03 | 28.57 | |
| Beta | 1.33 | 1.18 | 0.96 | |
| Price to Sales (TTM) | 1,217.66 | 42.73 | 10.02 | |
| Price to Book (MRQ) | 4.05 | 12.58 | 4.53 | |
| Price to Tangible Book (MRQ) | 4.44 | 18.14 | 5.33 | |
| Price to Cash Flow (TTM) | -- | 68.10 | 26.07 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.10 | 1.61 | |
| Dividend Yield - 5 Year Avg | -- | 0.05 | 1.35 | |
| Dividend 5 Year Growth Rate | -- | 0.79 | 6.52 | |
| Payout Ratio(TTM) | -- | 1.51 | 36.85 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 0.00 | 61.11 | 15.38 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 10.50 | 46.83 | 8.69 | |
| Sales - 5 Yr. Growth Rate | -13.73 | 33.28 | 10.31 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 25.13 | -9.16 | 18.28 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -73.33 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 22.24 | 7.10 | |
| Capital Spending - 5 Yr. Growth Rate | -7.03 | 24.81 | 7.93 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.77 | 2.47 |
| Current Ratio (MRQ) | 23.31 | 3.76 | 3.43 |
| LT Debt to Equity (MRQ) | 0.23 | 7.55 | 14.00 |
| Total Debt to Equity (MRQ) | 0.30 | 20.84 | 19.69 |
| Interest Coverage (TTM) | -- | 34.79 | 15.40 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 26.88 | 50.06 | |
| Gross Margin - 5 Yr. Avg. | -- | 59.71 | 51.22 | |
| EBITD Margin (TTM) | -12,221.81 | -- | -- | |
| EBITD - 5 Yr. Avg | -10,396.69 | -8.97 | 16.15 | |
| Operating Margin (TTM) | -12,556.37 | -107.66 | -7.35 | |
| Operating Margin - 5 Yr. Avg. | -10,931.68 | -25.48 | 11.44 | |
| Pre-Tax Margin (TTM) | -13,171.49 | -108.99 | -7.82 | |
| Pre-Tax Margin - 5 Yr. Avg. | -12,502.36 | -31.01 | 16.14 | |
| Net Profit Margin (TTM) | -13,190.06 | -114.67 | -11.61 | |
| Net Profit Margin - 5 Yr. Avg. | -12,507.01 | -36.34 | 11.33 | |
| Effective Tax Rate (TTM) | -- | 17.29 | 20.12 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 18.91 | 24.36 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 15,921 | 8,835,841 | 786,836,669 | |
| Net Income/Employee (TTM) | -2,100,025 | 1,777,667 | 92,111,001 | |
| Receivable Turnover (TTM) | 1.54 | 11.54 | 5.85 | |
| Inventory Turnover (TTM) | -- | 2.42 | 3.71 | |
| Asset Turnover (TTM) | 0.00 | 0.33 | 0.82 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -35.83 | 6.33 | 9.71 | |
| Return on Assets - 5 Yr. Avg. | -47.02 | 6.22 | 10.70 | |
| Return on Investment (TTM) | -37.11 | 7.69 | 12.16 | |
| Return on Investment - 5 Yr. Avg. | -50.56 | 8.15 | 13.61 | |
| Return on Equity (TTM) | -41.86 | 8.19 | 16.93 | |
| Return on Equity - 5 Yr. Avg. | -61.62 | 9.23 | 15.13 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 10.24 | 25.36 | -13.73 |
| EPS (TTM) % | 17.83 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Aurinia Pharmaceuticals Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -7.20 | -6.63 | 88 | 53 |
| 13 Week | -1.67 | -2.64 | 99 | 48 |
| 26 Week | 1.73 | -8.92 | 99 | 36 |
| 52 Week | 11.64 | 11.82 | 99 | 12 |
| YTD | -11.10 | -21.89 | 74 | 11 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 32.86% |
| # of Holders: | 100 |
| Total Shares Held: | 30,114,566 |
| 3 Mo. Net Change: | 7,612,770 |
| # New Positions: | 26 |
| # Closed Positions: | 6 |
| # Increased Positions: | 50 |
| # Reduced Positions: | 29 |
| # Net Buyers: | 21 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.